https://grouph.com/wp-content/uploads/2017/02/Interview_P.jpg 230 290 groupH https://grouph.com/wp-content/uploads/2022/03/GrouoH-logo-master.png groupH2018-12-03 14:36:122018-12-03 18:07:39EU Payer Opinion on Assessing Value in Rare Diseases
EU Payer Opinion on Assessing Value in Rare Diseases
groupH asked senior EU payers to comment on how they assess Value in Rare Diseases and how it is different from more prevalent indications.
Click below to watch one of the interviews, with Bruno Falissard. Bruno is a former member of the Transparency Commission at HAS, Psychiatrist and Biostatistician, and Head of Research Unit Inserm U669 on Eating Disorders in Teenagers.